this approach brings new hope that we can finally address the growing concern of obesity worldwide.

the small G protein family member, Cdc42, plays an important role in the progression of Alzheimer's disease.

TAK-279, which is a highly selective inhibitor of TYK2 enzymatic activity.

HRS-1893 works through a special mechanism that inhibits myocardial excessive contraction and is intended for the treatment of hypertrophic cardiomyopathy and heart failure caused by myocardial hypertrophy.

As the only Alzheimer's drug fully approved by the FDA in the last 20 years, it may genuinely bring a ray of hope to patients plagued by the disease worldwide.

TIGIT, a major immune checkpoint molecule, is expressed on the surface of T cells and natural killer (NK) cells.

What led to AbbVie's present success? And what lessons can other pharmaceutical companies learn from its success?

Unlike conventional chemotherapy, which can damage healthy cells, ADCs are intended to target and kill tumor cells while sparing healthy cells.

AZD4747, that shows promise in treating tumors with the KRAS G12C mutation.

KRAS G12C inhibitors that can penetrate the brain have a differentiated clinical advantage.

For most patients with severe depression, monoamine-targeted first or second-line treatments often cannot achieve sufficient therapeutic effects.

The world's first non-hormonal targeted drug for the treatment of moderate to severe vasomotor symptoms (VMS) caused by menopause.